Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa. Num. Pages Manejo clínico de las hiperprolactinemias. Clinical management of hyperprolactinemia. Visits. Download PDF. La frecuencia de hiperprolactinemia en esta entidad es del 13 al 59% y los . Artículo. B. Farzati,G. Mazziotti,G. Cuomo,M. Ressa,F. Sorvillo,G. Amato.
|Published (Last):||6 September 2016|
|PDF File Size:||6.59 Mb|
|ePub File Size:||7.4 Mb|
|Price:||Free* [*Free Regsitration Required]|
External radiation therapy is only reserved for residual tumor in patients who have undergone surgery and the entire tumor is not removed. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
Type 2 AIT is managed with glucocorticoids, beta-blockade, and rarely thyroidectomy. Recurrence is correlated to the duration of treatment with dopamine agonists, PRL levels at diagnosis, and initial tumor size.
Effects of hieprprolactinemia on pregnancy and embryo-fetal development: Hyperprolactinemia is a condition of elevated prolactin levels in blood which could be physiological, pathological, or idiopathic in origin. Malignant prolactinoma should be suspected in patients with no response to drug treatment or recurrence after surgery. Clinical significance of fibromyalgia syndrome in different Departamento de Medicina Interna.
Less data; appears safe. Ned Tijdschr Geneeskd,pp. Rev Med Hoperprolactinemia,pp. The incidence of malignant prolactinoma is very low. Subclinical hypothyroidism is defined by elevated serum TSH with normal peripheral free thyroid hormone levels.
Manejo clínico de las hiperprolactinemias | Revista Clínica Española (English Edition)
The efficacy of radiotherapy should always be weighed against the complications derived from the treatment. Even one normal value should be considered as normal and an isolated raised one should be discarded as spurious.
Pattern of increase in circulating prolactin levels during human gestation.
Physiological hyperprolactinemia is usually mild or moderate. Surgery is first-line therapy for acromegaly. The mean age at diagnosis is years, typically hieprprolactinemia years of symptoms prior to diagnosis.
Transsphenoidal surgery in patients who do not respond to any of the above regimens. The treatment of drug-induced hyperprolactinemia should be restricted to symptomatic patients in whom the concerned drug cannot be discontinued or replaced.
It is a common endocrine disorder of the hypothalamic-pituitary axis. The predominant physiologic consequence of hyperprolactinemia is hypogonadotropic hypogonadism HH which is due to suppression of pulsatile GnRH. Prognostic factors of low bone mineral density in systemic sclerosis. Dopamine agonists and pituitary tumor shrinkage.
Actual serum prolactin level is the result of a complex balance between positive and negative stimuli derived from both external and endogenous environments.
Possible mechanisms include increased arterial stiffness due to hypertrophy and fibrosis of the arterial muscular tunica. CiteScore measures average citations received per document published. Among its adverse effects considered as “very inusual” is included the ability to induce fibrotic changes in cardiac valvular tract first described in patients with Parkinson disease using doses higher than those usually used in atticulo treatment.
Continuing navigation will be considered as acceptance of this use. Unlike other tropic hormones secreted by the anterior pituitary gland, prolactin secretion is controlled primarily by inhibition from the articuol and it is not subject to negative feedback directly or indirectly by peripheral hormones.
The clinical presentation of PHPT has articuli over the past several years as disease detection has improved. Increased carotid arterial intima-media thickness IMTa marker of early atherosclerotic development, has also been described in GHD.
The Endocrine System and the Heart: A Review
Diagnosis, prophylaxis and treatment of osteoporosis. Clinicians should be aware of these conditions, since inappropriate treatments can result if they are not recognized. Support Center Support Hiperprolacyinemia. The aim of the treatment is reduction in tumor mass along with the correction of the biochemical consequences of the hormonal excess including restoration of fertility, prevention of bone loss, and suppression of galactorrhea.
The Endocrine System and the Heart: A Review | Revista Española de Cardiología (English Edition)
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Bromocriptine is the first option for this condition and has now been used for the longest period of time. In human reproduction, pathological hyperprolactinemia most commonly presents as an ovulatory disorder and is often associated with secondary amenorrhea or oligomenorrhea.
However, it also exerts metabolic effects, takes part in reproductive mammary development[ 8 ] and stimulates immune responsiveness. CiteScore measures average citations received per document published.